These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2254012)

  • 1. Humoral antibody response and protective immunity in swine following immunization with the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae.
    Devenish J; Rosendal S; Bossé JT
    Infect Immun; 1990 Dec; 58(12):3829-32. PubMed ID: 2254012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect enzyme-linked immunosorbent assay for detection of antibody to a 110,000-molecular-weight hemolysin of Actinobacillus pleuropneumoniae.
    Ma JN; Inzana TJ
    J Clin Microbiol; 1990 Jun; 28(6):1356-61. PubMed ID: 2380363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia.
    Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T
    J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of seroreactors to the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae in swine herds.
    Devenish J; Rosendal S; Bossé JT; Wilkie BN; Johnson R
    J Clin Microbiol; 1990 Apr; 28(4):789-91. PubMed ID: 2332472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a non-hemolytic mutant of Actinobacillus pleuropneumoniae serotype 5: role of the 110 kilodalton hemolysin in virulence and immunoprotection.
    Inzana TJ; Todd J; Ma JN; Veit H
    Microb Pathog; 1991 Apr; 10(4):281-96. PubMed ID: 1895928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae.
    Byrd W; Harmon BG; Kadis S
    Vet Immunol Immunopathol; 1992 Nov; 34(3-4):307-24. PubMed ID: 1455686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison.
    Fedorka-Cray PJ; Stine DL; Greenwald JM; Gray JT; Huether MJ; Anderson GA
    Vet Microbiol; 1993 Oct; 37(1-2):85-100. PubMed ID: 8296454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge.
    Hensel A; Stockhofe-Zurwieden N; Petzoldt K; Lubitz W
    Infect Immun; 1995 Aug; 63(8):3048-53. PubMed ID: 7622229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of protective immunity and inflammatory responses of pigs following immunization with different Actinobacillus pleuropneumoniae preparations with and without adjuvants.
    Hall W; Molitor TW; Joo HS; Pijoan C
    Vet Immunol Immunopathol; 1989 Sep; 22(2):175-86. PubMed ID: 2815578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pig lungs following an experimental challenge with Actinobacillus pleuropneumoniae serotype 1 and 5 in pigs inoculated with either hemolysin protein and/or outer membrane proteins.
    Madsen ME; Carnahan KG; Thwaits RN
    FEMS Microbiol Lett; 1995 Sep; 131(3):329-35. PubMed ID: 7557344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody- and cell-mediated immune responses of Actinobacillus pleuropneumoniae-infected and bacterin-vaccinated pigs.
    Furesz SE; Mallard BA; Bossé JT; Rosendal S; Wilkie BN; MacInnes JI
    Infect Immun; 1997 Feb; 65(2):358-65. PubMed ID: 9009283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state.
    Hensel A; Huter V; Katinger A; Raza P; Strnistschie C; Roesler U; Brand E; Lubitz W
    Vaccine; 2000 Jul; 18(26):2945-55. PubMed ID: 10825595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae.
    Nielsen R; van den Bosch JF; Plambeck T; Sørensen V; Nielsen JP
    Vet Microbiol; 2000 Jan; 71(1-2):81-7. PubMed ID: 10665536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-protection between Actinobacillus pleuropneumoniae biotypes-serotypes in pigs.
    Haesebrouk F; Van de Kerkhof A; Dom P; Chiers K; Ducatelle R
    Vet Microbiol; 1996 Oct; 52(3-4):277-84. PubMed ID: 8972053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ
    Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological cross-reactivity between a porcine Actinobacillus strain and Haemophilus pleuropneumoniae.
    Rosendal S; Mittal KR
    Can J Comp Med; 1985 Apr; 49(2):164-70. PubMed ID: 3926287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoserological comparison of 104-kilodalton proteins associated with hemolysis and cytolysis in Actinobacillus pleuropneumoniae, Actinobacillus suis, Pasteurella haemolytica, and Escherichia coli.
    Devenish J; Rosendal S; Johnson R; Hubler S
    Infect Immun; 1989 Oct; 57(10):3210-3. PubMed ID: 2674017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae.
    Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S
    Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.